Immune response to fungal infections

Veterinary Immunology and Immunopathology

Volumn 125, Issue 1-2, 2008, Pages 47-70

  Blanco, Jose L ^a   Garcia, Marta E ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aspergillus; Candida; Cryptococcus; Dermatophyte; Immunity; Malassezia; Pathogenicity; Pneumocystis

Indexed keywords

4 AMINOBENZOIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; COLONY STIMULATING FACTOR 1; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DERMATOVAC IV; FEO O VAX MC K; FUNGUS ANTIGEN; FUNGUS VACCINE; GAMMA INTERFERON; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INACTIVATED VACCINE; INSOL; INTERLEUKIN 10; INTERLEUKIN 6; LIVE VACCINE; PERMAVAX TRICHO; RINGVAC; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CONIDIUM; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CYTOKINE RELEASE; DERMATOMYCOSIS; DERMATOPHYTE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG EFFICACY; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION SENSITIVITY; INNATE IMMUNITY; INVASIVE CANDIDIASIS; MALASSEZIA PACHYDERMATIS; MUCOCILIARY CLEARANCE; MUCOSA; MYCELIUM; MYCOSIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; PNEUMOCYSTIS; PROTEIN FUNCTION; STOMATITIS; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON VERRUCOSUM; VACCINATION;

ANIMAL DISEASES; ANIMALS; ANTIBODY FORMATION; FUNGI; IMMUNITY, CELLULAR; MYCOSES;

ANIMALIA; ARTHRODERMATACEAE; ASPERGILLUS; CANDIDA; CANDIDA ALBICANS; CRYPTOCOCCUS GATTII; FUNGI; MALASSEZIA; MALASSEZIA PACHYDERMATIS; PNEUMOCYSTIS;

EID: 49049119030     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.04.020     Document Type: Article

References (186)

1. Aerts A.M., François I.E.J.A., Cammue B.P.A., and Thevissen K. The mode of antigungal action of plant, insect and human defensins. Cell. Mol. Life Sci. 65 (2008) 2069-2079
2. + T cells. Med. Mycol. 42 (2004) 15-25
3. Ahman S., Perrins N., and Bond R. Carriage of Malassezia spp. yeasts in healthy and seborrhoeic Devon Rex cats. Med. Mycol. 45 (2007) 449-455
4. Akamatsu H., Kamura J., Asada Y., Miyachi Y., and Niwa Y. Inhibitory effect of azelaic acid on neutrophil fractions: a posible cause for its efficacy in treating pathogenetically unrelated diseases. Arch. Dermatol. Res. 283 (1991) 162-166
5. Akerstedt J., and Vollset I. Malassezia pachydermatis with special reference to canine skin diseases. Br. Vet. J. 152 (1996) 269-281
6. Amitani R., Taylor G., Elezis E.N., Llewellyn-Jones C., Mitchell J., Kuze F., Cole P.J., and Wilson R. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect. Immun. 63 (1995) 3266-3271
7. Ashbee H.R. Recent developments in the immunology and biology of Malassezia species. FEMS Immunol. Med. Microbiol. 47 (2006) 14-23
8. Ashbee H.R. Update on the genus Malassezia. Med. Mycol. 45 (2007) 287-303
9. Ashbee H.R., and Evans E.G.V. Immunology of diseases associated with Malassezia species. Clin. Microbiol. Rev. 15 (2002) 21-57
10. Ashbee H.R., Fruin A., Holland K.T., Cunliffe W.J., and Ingham E. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp. Dermatol. 3 (1994) 227-233
11. Ashbee H.R., Ingham E., Holland K.T., and Cunliffe W.J. Cell-mediated immune response to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp. Dermatol. 3 (1994) 106-112
12. Baro T., Torres-Rodriguez J.M., Hermoso de Mendoza M., Morera Y., and Alia C. First identification of autochtonous Cryptococcus neoformonans var. gattii isolated from goats with predominantly severe pulmonary disease in Spain. J. Clin. Microbiol. 36 (1998) 458-461
13. Beck J.M., and Harmsen A.G. Lymphocites in host defense against Pneumocystis carinii. Semin. Respir. Infect. 13 (1998) 330-338
14. Bellocchio S., Bozza S., Montagnoli C., Perruccio K., Gaziano R., Pitzurra L., and Romani L. Immunity to Aspergillus fumigatus: the basis for immunotherapy and vaccination. Med. Mycol. 43 Suppl. I (2005) S181-S188
15. Berry W.L., and Leisewitz L. Multifocal Aspergillus terreus discospondylitis in two German shepherd dogs. J. S. Afr. Vet. Assoc. 67 (1996) 222-228
16. Blanco J.L., and Garcia M.E. Presente y futuro del diagnóstico inmunológico de las micosis animales. Rev. Iberoam. Micol. 17 (2000) S23-S28
17. Blanco J.L., Guedeja-Marron J., Blanco I., and Garcia M.E. Optimum incubation conditions for the isolation of yeasts from canine otitis externa. J. Vet. Med. B 47 (2000) 599-605
18. Blanco J.L., Hontecillas R., Bouza E., Blanco I., Pelaez T., Perez-Molina J., and Garcia M.E. Correlation between the elastase activity index and invasiveness of clinical isolates of Aspergillus fumigatus. J. Clin. Microbiol. 40 (2002) 1811-1813
19. Bozza S., Gaziano R., Spreca A., Bacci A., Montagnoli C., di Francesco P., and Romani L. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J. Immunol. 168 (2002) 1362-1371
20. Bozza S., Perruccio K., Montagnoli C., Gaziano R., Bellochio S., Burchielli E., Nkwanyuo G., Pitzurra L., Velardi A., and Romani L. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102 (2003) 3807-3814
21. Bromuro C., Torosantucci A., Gomez M.J., Urbani F., and Cassone A. Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans. J. Med. Vet. Mycol. 32 (1994) 447-459
22. Brown M.R., Thompson C.A., and Mohamed F.M. Systemic candidiasis in an apparently immunocompetent dog. J. Vet. Diagn. Invest. 17 (2005) 272-276
23. Brummer E., and Stevens D.A. Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum. Clin. Exp. Immunol. 102 (1996) 65-70
24. Butterworth S.J., Barr F.J., Pearson G.R., and Day M.J. Multiple discospondylitis associated with Aspergillus species infection in a dog. Vet. Rec. 136 (1995) 38-41
25. Cabañes F.J., Abarca M.L., and Bragulat M.R. Dermatophytes isolated from domestic animals in Barcelona, Spain. Mycopathologia 137 (1997) 107-113
26. Casadevall A. Antibody immunity and invasive fungal infections. Infect. Immun. 63 (1995) 4211-4218
27. Casadevall A., Feldmesser M., and Pirofski L.A. Induced humoral immunity and vaccination against major human fungal pathogens. Curr. Opin. Microbiol. 5 (2002) 386-391
28. Cassone A., Conti S., De Bernardis F., and Polonelli L. Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature?. Immunol. Today 18 (1997) 164-169
29. Cavallini E.M., Pescador C., Rozza D., Spanamberg A., Borba M.R., Ravazzolo A.P., Driemeier D., Guillot J., and Ferreiro L. Detection of Penumocystis spp. in lung samples from pigs in Brazil. Med. Mycol. 45 (2007) 395-399
30. Cenci E., Mencacci A., Del Sero G., Bacci A., Montagnoli C., d'Ostiani C.F., Mosci P., Bachmann M., Bistoni F., Kopf M., and Romani L. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J. Infect. Dis. 180 (1999) 1957-1968
31. Cenci E., Mencacci A., Bacci A., Bistoni F., Kurup V.P., and Romani L. T cell vaccination in mice with invasive pulmonary aspergillosis. J. Immunol. 165 (2000) 381-388
32. Cenci E., Mencacci A., Spreca A., Montagnoli C., Bacci A., Perruccio K., Velarde A., Magliani W., Conti S., Polonelli L., and Romani L. Protection of killer antiidiotypic, antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation. Infect. Immun. 70 (2002) 2375-2382
33. Chen G.H., Olszewski M.A., McDonald R.A., Wells J.C., Paine III R., Huffnagle G.B., and Toews G.B. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am. J. Pathol. 170 (2007) 1028-1040
34. Christin L., Wysong D.R., Meshulam T., Hastey R., Simons E.R., and Diamond R.D. Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect. Immun. 66 (1998) 1181-1189
35. Clemons K.V., Calich V.L.G., Burger E., Filler S.G., Graziutti M., Murphy J., Roilides E., Campa A., Dias M.R., Edwards J.E., Fu Y., Fernandes-Bordignon G., Ibrahim A., Katsifa H., Lamaignere C.G., Meloni-Bruneri L.H., Rex J., Savary C.A., and Xidieh C. Pathogenesis I: interactions of host cells and fungi. Med. Mycol. 38 Suppl. 1 (2000) 99-111
36. Clercx C., McEntee K., Snaps F., Jacquinet E., and Coignoul F. Bronchopulmonary and disseminated granulomatous disease associated with Aspergillus fumigatus and Candida species infection in a Golden Retriever. J. Am. Anim. Hosp. Assoc. 32 (1996) 139-145
37. Cox A.R. Immunology of the Fungal Diseases (1989), CRC Press, Florida, USA
38. Crameri R., and Blaser K. Allergy and immunity to fungal infections and colonization. Eur. Respir. J. 19 (2002) 151-157
39. Dahl M.V. Dermatophytosis and the immune response. Acad. Dermatol. 28 (1993) 519-523
40. Dallman M.J., Dew T.L., Tobias L., and Doss R. Disseminated aspergillosis in a dog with diskospondylitis and neurologic deficits. J. Am.Vet. Med. Assoc. 200 (1992) 511-513
41. Day M.J., and Penhale W.J. An immunohistochemical study of canine disseminated aspergillosis. Aust. Vet. J. 68 (1991) 383-386
42. Day M.J., and Penhale W.J. Humoral immunity in disseminated Aspergillus terreus infection in the dog. Vet. Microbiol. 16 (1998) 283-294
43. Day M.J., Eger C.E., Shaw S.E., and Penhale W.J. Immunologic study of systemic aspergillosis in German shepherd dogs. Vet. Immunol. Immunopathol. 9 (1985) 335-347
44. DeBoer D.J., and Moriello K.A. Humoral and cellular responses to Microsporum canis in naturally occurring feline dermatophytosis. J. Vet. Med. Mycol. 31 (1993) 121-132
45. DeBoer D.J., and Moriello K.A. Investigations of a killed dermatophyte cell-wall vaccine against infection with Microsporum canis in cats. Res. Vet. Sci. 59 (1995) 110-113
46. DeBoer D.J., Moriello K.A., and Cooley A.I. Immunological reactivity to intradermal dermatophyte antigens in cats with dermatophytosis. Vet. Dermatol. 2 (1991) 59-67
47. Deep Jr. G.S. Prospects for the development of fungal vaccines. Clin. Microbiol. Rev. 10 (1997) 585-596
48. Dei-Cas E. Pneumocystis infections: the iceberg?. Med. Mycol. 38 Suppl. 1 (2000) 23-32
49. Diamond R.D., and Bennett J.E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann. Intern. Med. 80 (1974) 176-181
50. Dumoulin A., Mazars E., Seguy N., Gargallo-Viola D., Vargas S., Cailliez J.C., Aliouat E.M., Wakefield A.E., and Dei-Cas E. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 671-678
51. Duncan C.G., Stephen C., and Campbell J. Evaluation of risk factors for Cryptococcus gattii infection in dogs and cats. J. Am. Vet. Med. Assoc. 228 (2006) 377-382
52. Duncan C.G., Stephen C., and Campbell J. Clinical characteristics and predictors of mortality for Cryptococcus gattii infection in dogs and cats of southwestern British Columbia. Can. Vet. J. 47 (2006) 993-998
53. Duong M., Ouellet N., Simard M., et al. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J. Infect. Dis. 178 (1998) 1472-1482
54. Edman J.K., Kovacs J.A., Masur H., Santi D.V., Elwood H.J., and Sogin M.L. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334 (1988) 519-522
55. Elad D., Lahav D., and Blum S. Transuterine transmisión of Aspergillus terreus in a case of disseminated canine aspergillosis. Med. Mycol. 46 (2008) 175-178
56. English K., Peters S.E., Meskell D.J., and Collins M.E. DNA analysis of Pneumocystis infecting a Cavalier King Charles Spaniel. J. Eukaryot. Microbiol. Suppl. (2001) 106S
57. Feldmesser M. Prospects of vaccines medically important fungi. Med. Mycol. 43 (2005) 571-587
58. Filler S.G., Swerdloff J.N., Hobbs C., and Luckett P.M. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63 (1995) 976-983
59. Fratti R.A., Belanger P.H., Ghannoum M.A., Edwards Jr. J.E., and Filler S.G. Endothelial cell injury caused by Candida albicans is dependent on iron. Infect. Immun. 66 (1998) 191-196
60. Furuta T., Fujiwara K., Yamanouchi K., and Veda K. Detection of antibodies to Pneumocystis carinii by enzyme-linked immunosorbent assay in experimentally infected mice. J. Parasitol. 71 (1985) 522-523
61. Gantner B.N., Simmons R.M., and Underhill D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24 (2005) 1277-1286
62. Ganz T. Immunology. Versatile defensins. Science 298 (2002) 977-979
63. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
64. Garcia M.E., and Blanco J.L. Principales enfermedades fúngicas que afectan a los animales domésticos. Rev. Iberoam. Micol. 17 (2000) S2-S7
65. Garcia M.E., Caballero J., Toni P., Garcia I., Martinez de Merlo E., Rollan E., Gonzalez M., and Blanco J.L. Disseminated mycoses in a dog by Paecilomyces sp. J. Vet. Med. A 47 (2000) 243-249
66. Garcia M.E., Caro A., Fragio C., Blanco I., and Blanco J.L. A clinical case of canine mycotic pneumonia. J. Vet. Med. A 48 (2001) 501-506
67. Garcia M.E., Caballero J., Cruzado M., Andrino M., Gonzalez-Cabo J.F., and Blanco J.L. The value of the determination of anti-Aspergillus IgG in the serodiagnosis of canine aspergillosis: comparison with galactomannan detection. J. Vet. Med. B 48 (2001) 743-750
68. Garcia M.E., Duran C., Cruzado M., Andrino M., and Blanco J.L. Evaluation of molecular and immunological techniques for the diagnosis of mammary aspergillosis in ewes. Vet. Microbiol. 98 (2004) 17-21
69. Garcia M.E., Guedeja-Marron J., Lazaro M., and Blanco J.L. Monitoring of canine dermatophytosis by an immunodiagnostic method. Vet. Rec. 154 (2004) 116-117
70. Garcia M.E., Lanzarot P., Lopez-Rodas V., Costas E., and Blanco J.L. Fungal flora in trachea of birds from a wildlife rehabilitation centre in Spain. Vet. Med. 52 (2007) 464-470
71. Gelatt K.N., Chrisman C.L., Samuelson D.A., Shell L.G., and Buergelt C.D. Ocular and systemic aspergillosis in a dog. J. Am. Anim. Hosp. Assoc. 27 (1991) 427-431
72. Gene J., Blanco J.L., Cano J., Garcia M.E., and Guarro J. The new filamentous fungus Sagenomella chlamydospora responsible for a disseminated infection in a dog. J. Clin. Microbiol. 41 (2003) 1722-1725
73. Goldman D.L., Khine H., Abadi J., Lindenberg D.J., Pirofski L., Niang R., and Casadevall A. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107 (2001) E66
74. Gonzalez C.E., Lyman C.A., Lee S., Del Guercio C., Roilides E., Bacher J., Gehrt A., Fenerstein E., Toscos M., and Walsh T.J. Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus. Cytokine 15 (2001) 87-95
75. Griffin C.E. Otitis externa and otitis media. In: Griffin C.E., Kwochka K.W., and MacDonald J.M. (Eds). Current Veterinary Dermatology (1993), Mosby Year Book, St Louis 244-262
76. Gudding R., and Lund A. Immunoprofilaxis of bovine dermatophytosis. Can. Vet. J. 36 (1995) 302-306
77. Guerin S.R., Walker M.C., and Kelly D.F. Cavitating mycotic pulmonary infection in a german shepherd dog. J. Small Anim. Pract. 34 (1993) 36-39
78. Guillot J., and Bond R. Malassezia pachydermatis: a review. Med. Mycol. 37 (1999) 295-306
79. Han Y., and Cutler J.E. Antibody response that protect against disseminated candidiasis. Infect. Immun. 63 (1995) 2714-2719
80. He W., Casadevall A., Lee S.C., and Goldman D.L. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococosis. Infect. Immun. 71 (2003) 930-936
81. Hernando F.L., Estevez J.J., Cebrian M., Poulain D., and Ponton J. Identification of Candida albicans cell wall antigens lost during subculture in synthetic media. J. Med. Vet. Mycol. 31 (1993) 227-237
82. Hostetter M.K. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin. Microbiol. Rev. 7 (1994) 29-42
83. Hunsaker B.D., and Perino L.J. Efficacy of intradermal vaccination. Vet. Immunol. Immunopathol. 79 (2001) 1-13
84. Ibrahim-Granet O., Phillipe B., Boleti H., Boisvieux-Ulrich E., Grenet D., Stern M., and Latge J.P. Phagocytic and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect. Immun. 71 (2003) 891-903
85. Jadhav V.J., and Pal M. Canine mycotic stomatitis due to Candida albicans. Rev. Iberoam. Micol. 23 (2006) 233-234
86. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Ann. Rev. Immunol. 20 (2002) 197-216
87. Jang S.S., Dorr T.E., Biberstein E.L., and Wong A. Aspergillus deflectus infection in four dogs. J. Med. Vet. Mycol. 24 (1986) 95-104
88. Jensen H.E., Basse A., and Aalbaek B. Mycosis in the stomach compartiments of cattle. Acta Vet. Scand. 30 (1989) 409-423
89. Kaplan G., Walsh G., Guido L.S., Meyn P., Burkhardt R.A., Abalos R.M., Barker J., Frindt P.A., Fajardo T.T., and Celona R. Novel responses on human skin to intradermal recombinant granulocyte/macrophage colony stimulating factor: Langerhans cells recruitment, keratinocyte growth, and enhance wound healing. J. Exp. Med. 175 (1992) 1717-1728
90. Kauffman A.C., Green C.E., Selcer B.A., Styles M.E., and Mahaffey E.A. Systemic aspergillosis in a dog and treatment with hamycin. J. Am. Anim. Hosp. Assoc. 30 (1994) 132-136
91. Kesavan S.A., Walters C.E., Holland K.T., and Ingham E. The effects of Malassezia on pro-inflammatory cytokine production by human peripheral blood mononuclear cells in vitro. Med. Mycol. 36 (1998) 97-106
92. Kieffer M., Bergbrant I.M., Faergemann J., Jemec G.B., Ottevanger V., Stahlskov P., and Svejgaard E. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J. Am. Acad. Dermatol. 22 (1990) 739-742
93. Klotz S.A. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin. Infect. Dis. 14 (1992) 340-347
94. Kondo H., Hikita M., Ito M., and Kadota K. Immunohistochemical study of Pneumocystis carinii infection in pigs: evaluation of Pneumocystis pneumonia and a retrospecive investigation. Vet. Rec. 147 (2000) 544-549
95. Kozel T.R. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9 (1996) 34-46
96. Kullberg B.J., Netea M.G., Vonk A.G., and van der Meer J.W. Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice. FEMS Immunol. Med. Microbiol. 26 (1999) 299-307
97. Kuwamura M., Ide M., Yamate J., Shiraishi Y., and Kotani T. Systemic candidiasis in a dog developing spondylitis. J. Vet. Med. Sci. 68 (2006) 1117-1119
98. Kwon-Chung K.J., Sorrell T.C., Dromer F., Fung E., and Levitz S.M. Cryptococcosis: clinical and biological aspects. Med. Mycol. 38 Suppl. 1 (2000) 205-213
99. Las Heras A., Domínguez L., Lopez I., Paya M.J., Peña L., Mazzucchelli F., Garcia L.A., and Fernández-Garayzabal J.F. Intramammary Aspergillus fumigatus infection in dairy ewes associated with antibiotic dry therapy. Vet. Rec. 147 (2000) 578-580
100. Latge J.P. Aspergillus fumigatus and Aspergillosis. Clin. Microbiol. Rev. 12 (1999) 310-350
101. Lehmann P.F. Immunology of fungal infections in animals. Vet. Immunol. Immunopathol. 10 (1985) 33-69
102. Lenard Z.M., Lester N.V., O'Hara A.J., Hopper B.J., and Lester G.D. Disseminated cryptococcosis including osteomyelitis in a horse. Aust. Vet. J. 85 (2007) 51-55
103. Littman M.P., and Goldschmidt M.H. Systemic paecilomycosis in a dog. J. Am. Vet. Med. Assoc. 191 (1987) 445-447
104. MacNeill A.L., Alleman A.R., Fanklin R.P., Long M., Giguere S., Uhl E., Lopez-Martinez A., and Wilkerson M. Pneumonia in a Paso-Fino mare. Vet. Clin. Pathol. 32 (2003) 73-76
105. Madan T., Kaur S., Saxena S., Singh M., Kishore U., Thiel S., Reid K.B.M., and Sarma P.U. Role of collectins in innate immunity against aspergillosis. Med. Mycol. 43 Suppl. I (2005) S155-S163
106. Markaryan A., Morozova I., Yu H., and Kolattukudy P.E. Purification and characterization of an elastinolytic metalloprotease from Aspergillus fumigatus and immuno-electron microscopic evidence of secretion of this enzyme by the fungus. Infect. Immun. 62 (1994) 2149-2157
107. McCormack F.X., and Whitsett J.A. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Invest. 109 (2002) 707-712
108. Medzhitov R., and Janeway Jr. C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91 (1997) 295-298
109. Mehrad B., and Standiford T.J. Role of cytokines in pulmonary antimicrobial host defense. Immunol. Res. 20 (1999) 15-27
110. Meier A., Kirschning C.J., Nikolaus T., Wagner H., Heesemann J., and Ebel F. Toll-like receptor (TLR) and TLR4 are essential for Aspergillus induced activation of murine macrophages. Cell. Microbiol. 5 (2003) 569-570
111. Mignon B.R., Coignoul F., Leclipteux T., Focant C., and Losson B.J. Histopathological pattern and humoral immune response to a crude exo-antigen and purified keratinase of Microsporum canis in symptomatic and asymptomatic infected cats. Med. Mycol. 37 (1999) 1-9
112. Mignon B.R., Leclipteux T., Focant C.H., Nikkels A.J., Pierard G.E., and Losson B.J. Humoral and cellular immune response to a crude exoantigen and purified keratinase of Microsporum canis in experimentally infected guinea pigs. Med. Mycol. 37 (1999) 123-129
113. Mittag H. Fine structural investigation of Malassezia furfur. Part II. The envelope of the yeast cells. Mycoses 38 (1995) 13-21
114. Morris D.O., and Rosser E.J. Immunologic aspects of Malassezia dermatitis in patients with canine atopic dermatitis. Proceedings of the 11th Annual Meeting American Academy of Veterinary Dermatology. American College of Veterinary Dermatology, Santa Fe, USA (1995)
115. Morrison B.E., Park S.J., Mooney J.M., and Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 112 (2003) 1862-1870
116. Mullanery T.P., Levin S., and Indrieri R.J. Disseminated aspergillosis in a dog. J. Am. Vet. Med. Assoc. 182 (1983) 516-518
117. Murphy J.W. Clearance of Cryptococcus neoformans from immunologically suppressed mice. Infect. Immun. 57 (1989) 1946-1952
118. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., and Power C.A. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000) 145-176
119. Netea M.G., Van der Graaf C.A.A., Vonk A.G., Verschveren I., Van der Meer J.W., and Kullberg B.J. The role of toll-like receptor (TLR) 2 and TLR 4 in the host defence against disseminated candidiasis. J. Infect. Dis. 185 (2002) 1483-1489
120. Netea M.G., Warris A., Van der Meer J.W., Fenton M.J., Verver-Janssen T.J., Jacobs L.E., Andresen T., Verweij P.E., and Kullberg B.J. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J. Infect. Dis. 188 (2003) 320-326
121. Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A., Van der Meer J.W., van Krieken J.H., Hortung T., Adema G., and Kullberg B.J. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of SL-10 and regulatory T cells. J. Immunol. 172 (2004) 3712-3718
122. Netea M.G., Ferwerda G., Van der Graaf C.A.A., Van der Meer J.W., and Kullberg B.J. Recognition of fungal pathogens by Toll-like receptors. Curr. Pharm. Des. 12 (2006) 4195-4201
123. O'Garra A., McEvoy L.M., and Zlotnik A. T-cell subsets: chemokine receptors guide the way. Curr. Biol. 8 (1998) 646-649
124. de Oliveira M.A.M., Carvalho L.P., Gomes M.S., Baceller O., Barros T.F., and Carvalho E.M. Microbiological and immunological features of oral candidiasis. Microbiol. Immunol. 51 (2007) 713-719
125. Ordeix L., Galeotti F., Scarampella F., Dedola C., Bardasí M., Romano E., and Fondati A. Malassezia spp. Overgrowth in allergic cats. Vet. Dermatol. 18 (2007) 316-323
126. Orozco A.S., Zhon X., and Filler S.G. Mechanisms of the pro-inflammatory response of endothelial cells to Candida albicans infection. Infect. Immun. 68 (2000) 1134-1141
127. Osawa H.R.C., Summerbell R.C., Clemons K.V., Koga T., Ron Y.P., Rashid A., Sohnle P.G., Stevens D.A., and Tsuboi R. Dermatophytes and the host defence. Med. Mycol. 36 (1998) S166-S173
128. Paris S., Boisvieux-Ulrich E., Crestani B., Houcine O., Taramelli D., Lombardi L., and Latge J.P. Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells. Infect. Immun. 65 (1997) 1510-1514
129. Pastor J., Pumarola M., Cuenca R., and Lavin S. Systemic aspergillosis in a dog. Vet. Rec. 132 (1993) 412-413
130. Patterson J.M., Rosendal S., Humphrey J., and Teeter W.G. A case of disseminated paecilomycoses in the dog. J. Am. Anim. Hosp. Assoc. 19 (1983) 569-574
131. Peeters D., Day M.J., and Clercx C. An immunohistochemical study of canine nasal aspergillosis. J. Comp. Pathol. 132 (2005) 283-288
132. Peeters D., Peters I.R., Helps C.R., Gabriel A., Day M.J., and Clercx C. Distinct tissue cytokine and chemokine mRNA expression in canine sino-nasal aspergillosis and idiopathic lymphoplasmacyte rhinitis. Vet. Immunol. Imunopathol. 117 (2007) 95-105
133. Perez J., Mozos E., Chacon F., Paniagua J., and Day M.J. Disseminated aspergillosis in a dog: an immunohistochemical study. J. Comp. Pathol. 115 (1996) 191-196
134. Phadke A.P., and Mehrad B. Cytokines in host defense against Aspergillus: recent advances. Med. Mycol. 43 Suppl. I (2005) S173-S176
135. Pier A.C., and Zancanella P.J. Immunization of horses against dermatophytosis caused by Trichophyton equinum. Equine Pract. 15 (1993) 23-27
136. Pier A.C., Ellis J.A., and Mills K.W. Development of immune response in experimental bovine Trichophyton verrucosum infection. Vet. Dermatol. 3 (1993) 131-138
137. Pier A.C., Hodges A.B., Lauze J.M., and Raisbeck M. Experimental immunity to Microsporum canis and cross reactions with other dermatophytes of veterinary importance. J. Med. Vet. Mycol. 33 (1995) 93-97
138. Polonelli L., Casadevall A., Han Y., Bernardis F., Kirkland T.N., Matthews R.C., Adriani D., Boccanera M., Burnie J.P., Cassone A., Conti S., Cutler J.E., Frazzi R., Gregory C., Hodgetts S., Illidge C., Magliani W., Rigg G., and Santoni G. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med. Mycol. 38 Suppl. 1 (2000) 281-292
139. Richardson M.D., and Shankland G.S. Enhanced phagocytosis and intracellular killing of Pityrosporum ovale by human neutrophils after exposure to ketoconazole is correlated to changes of the yeast cell surface. Mycoses 34 (1991) 29-33
140. Rodriguez-Adrian L.J., Grazzintti M.L., Rex J.H., and Anaissie E.J. The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?. Clin. Infect. Dis. 26 (1998) 1270-1278
141. Roeder A., Kirschning C.J., Rupec R.A., Schaller M., Weindl G., and Korting H.C. Toll-like receptors as key mediators in innate antifungal immunity. Med. Mycol. 42 (2004) 485-498
142. Roilides E., and Walsh T. Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp. Med. Mycol. 42 (2004) 1-13
143. Roilides E., Uhlig K., Venzon D., Pizzo P.A., and Walsh T.J. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 61 (1993) 1185-1193
144. Roilides E., Sein T., Holmes A., Chanok S., Blake C., Pizzo P.A., and Walsh T.J. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 172 (1995) 1028-1034
145. Roilides E., Dimitriadou-Georgiadou A., Sein T., Kadiltsoglou I., and Walsh T.J. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect. Immun. 66 (1998) 5999-6003
146. Roilides E., Tsaparidou S., Kadiltsoglou I., Sein T., and Walsh T.J. Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway. Infect. Immun. 67 (1999) 3047-3050
147. Roilides E., Lyman C.A., Sein T., Gonzalez C., and Walsh T.J. Antifungal activity of splenic, liver and pulmonary macrophages against Candida albicans and effects of macrophage colony-stimulating factor. Med. Mycol. 38 (2000) 161-168
148. Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2 (1999) 363-367
149. Romani L. Immunity to fungal infections. Nat. Rev. Immunol. 4 (2004) 1-23
150. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
151. Rossychuck R.A.W. Management of otitis externa. Vet. Clin. North Am. Small Anim. Pract. 24 (1994) 921-995
152. Rybnikar A., Vrzal V., and Chumela J. Protective efficacy of vaccines against bovine dermatophytosis after double and single vaccination. Mycoses 41 (1998) 83-86
153. Sandhu D.K., Sandhu R.S., Khan Z.U., and Damodaran V.N. Conditional virulence of a p-aminobenzoic acid-requiring mutant of Aspergillus fumigatus. Infect. Immun. 13 (1976) 527-532
154. Smith P.D., Lamerson C.L., Banks S.M., Saini S.S., Wahl L.M., Calderone R.A., and Wahl S.M. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J. Infect. Dis. 161 (1990) 999-1005
155. Sohnle P.G. Dermatophytosis. In: Murphy J.W., Friedman H., and Bendinello M. (Eds). Fungal Infections and Immune Response (1993), Plenum, New York 27-47
156. Sohnle P.G., and Collins-Lech C. Relative antigenicity of P. orbiculare and C. albicans. J. Invest. Dermatol. 75 (1980) 279-283
157. Sohnle P.G., and Collins-Lech C. Activation of complement by Pityrosporum orbiculare. J. Invest. Dermatol. 80 (1983) 93-97
158. Sparkes A.H., Stokes R., and Gruffydd-Jones T.J. Humoral immune response in cats with dermatophytosis. Am. J. Vet. Res. 54 (1993) 1869-1873
159. Sparkes A.H., Stokes R., and Gruffydd-Jones T.J. SDS-PAGE separation of dermatophyte antigens, and western immunoblotting in feline dermatophytosis. Mycopathologia 128 (1994) 91-98
160. Sparkes A.H., Stokes R., and Gruffydd-Jones T.J. Experimental Microsporum canis infection in cats: correlation between immunological and clinical observations. J. Med. Vet. Mycol. 33 (1995) 177-184
161. Starkey R.J., and McLoughlin M.A. Treatment of renal aspergillosis in a dog using nephrostomy tubes. J. Vet. Intern. Med. 10 (1996) 336-338
162. Steele C., Shellito J.D., and Kolls J.K. Immunity against the opportunistic fungal pathogen Pneumocystis. Med. Mycol. 43 (2005) 1-19
163. Steinstraesser L., Koehler T., Jacobsen F., Daigeler A., Goertz O., Langer S., Kesting M., Steinau H., Eriksson E., and Hirsch T. Host defense peptides in wound healing. Mol. Med. (2008) 10.2119/2008-00002
164. Stevens D.A., Walsh T.J., Bistoni F., Cenci E., Clemons K.V., Del Sero G., Fe d'Ostiani C., Kullberg B.J., Mencacci A., Roilides E., and Romani L. Citokynes and mycoses. Med. Mycol. 36 Suppl. 1 (1998) S174-S182
165. Stringer J.R., Beard C.B., Miller R.F., and Wakefield A.E. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg. Infect. Dis. 8 (2002) 891-896
166. Suter M.M. Intercellular communication in inflammatory and immune-mediated skin diseases. Proceedings 10th European Society of Veterinary Dermatology Congress. Denmark (1993) 165-180
167. Suzuki T., Ohno N., Oshima Y., and Yadomae T. Activation of the complement system, alternative and classical pathways, by Malassezia furfur. Pharm. Pharmacol. Lett. 8 (1998) 133-136
168. Takahashi M., Ushijima T., and Ozaki Y. Biological activity of Pityrosporum. II. Antitumor and immune stimulating effect of Pityrosporum in mice. J. Natl. Cancer Inst. 77 (1986) 1093-1097
169. Tell L.A. Aspergillosis in mammals and birds: impact on veterinary medicine. Med. Mycol. 43 Suppl. 1 (2005) S71-S73
170. Teunissen M.B.M. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review with emphasis on human Langerhans cells. Histochemistry 24 (1992) 697-796
171. Traynor T.R., and Huffnagle G.B. Role of chemokines in fungal infections. Med. Mycol. 39 (2001) 41-50
172. Uicker W.C., Doyle H.A., McCracken J.P., Langlois M., and Buchanan K.L. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Med. Mycol. 43 (2005) 27-38
173. Van de Wetering J.K., van Golde L.M., and Batenburg J.J. Collectins: players of the innate immune system. Eur. J. Biochem. 1 (2004) 1229-1249
174. Wagner D.K., and Sohnle P.G. Cutaneous defenses against dermatophytes and yeasts. Clin. Microbiol. Rev. 8 (1995) 317-335
175. Walsh T.J., Roilides E., Cortez K., Kottilil S., Bailey J., and Lyman C.A. Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. Med. Mycol. 43 Suppl. I (2005) S165-S167
176. Wang J.E., Warris A., Ellingsen E.A., Jorgensen P.F., Flo T.H., Espevik T., Solberg R., Verweij P.E., and Aasen A.O. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect. Immun. 69 (2001) 2402-2406
177. Watanabe S., Kano R., Sato H., Nakamura Y., and Hasegawa A. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J. Invest. Dermatol. 116 (2001) 769-773
178. Watson P.J., Wotton P., Eastwood J., Swift S.T., Jones B., and Day M.J. Immunoglobulin deficiency in Cavalier King Charles spaniels with Pneumocystis pneumonia. J. Vet. Intern. Med. 20 (2006) 523-527
179. Watt P.R., Robins G.M., Galloway A.M., and O'Boyle D.A. Disseminated opportunistic fungal disease in dogs: 10 cases (1982-1990). J. Am. Vet. Med. Assoc. 207 (1995) 67-70
180. Wawrzkievicz K., and Wawrzkievicz J. An inactivated vaccine against ringworm. Comp. Immun. Microbiol. Infect. Dis. 15 (1992) 31-40
181. Wilson S.M., and Odeon A. Disseminated Aspergillus terreus infection in a dog. J. Am. Anim. Hosp. Assoc. 28 (1992) 447-450
182. Wright J.R. Immunomodulatory functions of surfactant. Physiol. Rev. 77 (1997) 931-962
183. Wuthrich M., Filutowicz H.I., and Klein B.S. Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance. J. Clin. Invest. 106 (2000) 1381-1389
184. Zanatta R., Miniscalco B., Guarro J., Gene J., Capucchio M.T., Gallo M.G., Mikulicich B., and Peano A. A case of disseminated mycosis in a german shepherd dog due to Penicillium pururogenum. Med. Mycol. 44 (2006) 93-97
185. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
186. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127